Traci R. Tuttle, Ph.D.
Affiliations: | 2013 | Cell and Molecular Biology | University of Cincinnati, Cincinnati, OH |
Area:
Molecular Biology, Cell BiologyGoogle:
"Traci Tuttle"Parents
Sign in to add mentor| Nira Ben-Jonathan | grad student | 2013 | University of Cincinnati | |
| (Placental lactogen in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tuttle TR, Takiar V, Kumar B, et al. (2016) Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells. Cancer Letters |
| Tuttle TR, Mierzwa ML, Wells SI, et al. (2015) The cyclic GMP/protein kinase g pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer Letters |
| Tuttle TR, Hugo ER, Tong WS, et al. (2014) Placental lactogen is expressed but is not translated into protein in breast cancer. Plos One. 9: e87325 |
| Tuttle T, Tong W, Casper K, et al. (2014) Expression and Therapeutic Applications of Dopamine Receptors in Head-and-Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 88: 517 |
| Idelman G, Jacobson EM, Tuttle TR, et al. (2011) Lactogens and estrogens in breast cancer chemoresistance. Expert Review of Endocrinology & Metabolism. 6: 411-422 |
| Jacobson EM, Hugo ER, Tuttle TR, et al. (2010) Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends in Endocrinology and Metabolism: Tem. 21: 691-8 |
| Lapensee EW, Tuttle TR, Fox SR, et al. (2009) Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environmental Health Perspectives. 117: 175-80 |